Ownership history in CAXTON ASSOCIATES LP · 6 quarters on record
This page tracks every 13F SEC filing in which CAXTON ASSOCIATES LP reported a position in AGIOS PHARMACEUTICALS INC (AGIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | REDUCED | 8,544 | -28,909 | -77.2% | 0.01% | $380K | $44.43 |
| 2024 Q2 | ADDED | 37,453 | +264 | +0.7% | 0.06% | $1.6M | $43.12 |
| 2024 Q1 | ADDED | 37,189 | +23,230 | +166.4% | 0.06% | $1.1M | $29.24 |
| 2022 Q4 | REDUCED | 13,959 | -9,501 | -40.5% | 0.03% | $392K | $28.08 |
| 2022 Q3 | ADDED | 23,460 | +2,232 | +10.5% | 0.09% | $663K | $28.28 |
| 2022 Q2 | INITIATED | 21,228 | — | — | 0.05% | $471K | $22.17 |
As of 2025 Q4 — sorted by position size